Breast cancer could be divided into 4 molecular subtypes categorized according to ER or PR expression and HER2 gene amplification, each molecular subtype of breast cancer means a different distinct risk profile and treatment strategy (19–21). This evidence concerns the gene PGR and breast cancer.